Innovative Healthcare Solutions, Delivered
Innovative Healthcare Solutions, Delivered

Equipment and Consumables: D-Dimer

What problem does D-Dimer address?

D-Dimer helps to reduce unnecessary referrals and speeds up diagnosis of Venous Thromboembolism (VTE); by enabling the GP's Nursing Staff to view the test results whilst the patient is still in the surgery.

Setting

Primary Care

Disease / Clinical Area

Venous Thromboembolism (VTE)

These are used in the diagnosis of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) and Disseminated Intravascular Coagulation (DIC).

Prevalence

140,000 patients per year present with query DVT to primary care.

With 80% - 90% of these referred patients not having DVT, there is a significant opportunity to reduce cost by identifying which patients can have DVT excluded in Primary Care.

Whilst the number of low risk and negative d-dimer has yet to be fully examined, the current examples from CCGs utilising point of care D-Dimer in conjunction with a low risk probability score have shown that referrals have been reduced by 50%.

Patient Benefits

Early exclusion of DVT (VTE) when used in conjunction with a pre-test probability score. Reduced referrals to secondary care outpatient clinics or Emergency Departments. Easier access to services for high risk patients due to reduced demand.

Primary Care clinicians can initiate preventative treatment in these patients prior to final diagnosis. Patients who have DVT excluded benefit from the reassurance this brings and also have a differential diagnosis considered earlier.

Cost Benefit Analysis

Whilst the number of low risk and negative d-dimer has yet to be fully examined, the current examples from CCGs utilising point of care D-Dimer in conjunction with a low risk probability score have shown that referrals have been reduced by 50%.

The financial implications are a little less clear as some patients attract the A&E tariff only, the majority of patients attract the Outpatient referral tariff and a smaller number, usually those at higher risk, attract admission tariffs.

Assuming every patient was referred to an Outpatient Clinic which is seen currently as a cost effective way of managing these patients, we would see a cost nationally of £30.8M for these referrals. (assuming £220 per outpatient referral: a non-elective admission for DVT assessment is up to £2065)

Savings

140,000 patients presenting to Primary Care

All referred patients cost £30.8M

Cost of D-Dimer test in Primary Care to exclude DVT in Low Risk patients; assuming 50% of all presenters are low risk and have DVT excluded £1.05M

70,000 patients having DVT excluded, and hence not referred to Outpatient Clinic, would save £15.4M in referral charges alone, less the cost of the D-Dimer test at £15 per test = £14.35M pa saving

Purchase D-Dimer Kits

We supply Rapid D-Dimer Kits

These are used in the diagnosis of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) and Disseminated Intravascular Coagulation (DIC).

They can be used by GP's Nursing Staff etc. in the GP surgery so reducing the need for long waiting times for hospital appointments and the results can be viewed within 10 minutes, whilst the patient is still at the surgery.

The test uses whole blood or plasma (e.g. finger-prick), dropped onto a kit, which is then mixed with buffer drops giving a clear reading on the test kit itself; so there is no need for any other expensive equipment.

The kits do not need any special storage procedures; so they can be kept at room temperature in a cupboard. Each kit comes as a box of either 10 or 20 and have a shelf life of up to 21 months.

dot Cost per box of 20 kitsRapid D-Dimer = £150 + VAT


Oberoi Consulting can also supply a wide variety of other Near Patient Testing kits and equipment; so, if what you require isn't listed, do not hesitate to contact us, and we will do our best to help.